Cargando…
Identification of Molecular Markers of Clozapine Action in Ketamine-Induced Cognitive Impairment: A GPCR Signaling PathwayFinder Study
Background: Cognitive disorders associated with schizophrenia are closely linked to prefrontal cortex (PFC) dysfunction. Administration of the non-competitive NMDA receptor antagonist ketamine (KET) induces cognitive impairment in animals, producing effects similar to those observed in schizophrenic...
Autores principales: | Korlatowicz, Agata, Kuśmider, Maciej, Szlachta, Marta, Pabian, Paulina, Solich, Joanna, Dziedzicka-Wasylewska, Marta, Faron-Górecka, Agata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621432/ https://www.ncbi.nlm.nih.gov/pubmed/34830086 http://dx.doi.org/10.3390/ijms222212203 |
Ejemplares similares
-
Repeated Clozapine Increases the Level of Serotonin 5-HT(1A)R Heterodimerization with 5-HT(2A) or Dopamine D(2) Receptors in the Mouse Cortex
por: Szlachta, Marta, et al.
Publicado: (2018) -
Effect of clozapine on ketamine-induced deficits in attentional set shift task in mice
por: Szlachta, M., et al.
Publicado: (2017) -
Restraint Stress in Mice Alters Set of 25 miRNAs Which Regulate Stress- and Depression-Related mRNAs
por: Solich, Joanna, et al.
Publicado: (2020) -
Habenula as a Possible Target for Treatment-Resistant Depression Phenotype in Wistar Kyoto Rats
por: Korlatowicz, Agata, et al.
Publicado: (2022) -
Altered Intracellular Signaling Associated with Dopamine D2 Receptor in the Prefrontal Cortex in Wistar Kyoto Rats
por: Korlatowicz, Agata, et al.
Publicado: (2023)